Presenters:
Bartley Weaver, DO
Pediatric Resident
Geisinger
 
Nicole Torralba, MD
Pediatric Resident
Geisinger
 
Moderator:
Frank Maffei, MD
Janet Weis Children's Hospital
Geisinger
 
Objectives:
  • Analyze RSV Epidemiology
  • Analyze efficacy and safety of maternal RSVpreF vaccine (Abrysvo)
  • Discuss Nirsevimab (Beyfortus)
  • Review the role of Pavlizumab (Synagis)
  • Assess Nirsevimab availability during the 2023-2024 RSV season
  • Evaluate Geisinger Vaccine Roll Out
Session date: 
11/28/2023 - 10:29am EST
Location: 
Pediatric Resident Conference Room, Geisinger
Danville, PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.